294 related articles for article (PubMed ID: 1713692)
61. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane.
Jabbar MA; Nayak DP
J Virol; 1990 Dec; 64(12):6297-304. PubMed ID: 2243395
[TBL] [Abstract][Full Text] [Related]
62. The gp120 envelope of HIV-1 binds peptides in a similar manner to human leukocyte antigens.
Sheikh MJ; Ongrádi J; Austen BM; Dalgleish AG
AIDS; 1995 Nov; 9(11):1229-35. PubMed ID: 8561975
[TBL] [Abstract][Full Text] [Related]
63. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding.
Olshevsky U; Helseth E; Furman C; Li J; Haseltine W; Sodroski J
J Virol; 1990 Dec; 64(12):5701-7. PubMed ID: 2243375
[TBL] [Abstract][Full Text] [Related]
64. B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4.
Forsell MN; Dey B; Mörner A; Svehla K; O'dell S; Högerkorp CM; Voss G; Thorstensson R; Shaw GM; Mascola JR; Karlsson Hedestam GB; Wyatt RT
PLoS Pathog; 2008 Oct; 4(10):e1000171. PubMed ID: 18833294
[TBL] [Abstract][Full Text] [Related]
65. Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120.
Finberg RW; Diamond DC; Mitchell DB; Rosenstein Y; Soman G; Norman TC; Schreiber SL; Burakoff SJ
Science; 1990 Jul; 249(4966):287-91. PubMed ID: 2115689
[TBL] [Abstract][Full Text] [Related]
66. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
Hoffman TL; LaBranche CC; Zhang W; Canziani G; Robinson J; Chaiken I; Hoxie JA; Doms RW
Proc Natl Acad Sci U S A; 1999 May; 96(11):6359-64. PubMed ID: 10339592
[TBL] [Abstract][Full Text] [Related]
67. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
[TBL] [Abstract][Full Text] [Related]
68. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
[TBL] [Abstract][Full Text] [Related]
69. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies.
Xiang SH; Doka N; Choudhary RK; Sodroski J; Robinson JE
AIDS Res Hum Retroviruses; 2002 Nov; 18(16):1207-17. PubMed ID: 12487827
[TBL] [Abstract][Full Text] [Related]
70. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M
J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463
[TBL] [Abstract][Full Text] [Related]
71. Contribution of hypervariable domains to the conformation of a broadly neutralizing glycoprotein 120 epitope.
Lee CN; Robinson J; Mazzara G; Cheng YL; Essex M; Lee TH
AIDS Res Hum Retroviruses; 1995 Jul; 11(7):777-81. PubMed ID: 7546903
[TBL] [Abstract][Full Text] [Related]
72. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4.
Weinberg J; Liao HX; Torres JV; Matthews TJ; Robinson J; Haynes BF
AIDS Res Hum Retroviruses; 1997 May; 13(8):657-64. PubMed ID: 9168234
[TBL] [Abstract][Full Text] [Related]
73. Synthesis, oligomerization, and biological activity of the human immunodeficiency virus type 2 envelope glycoprotein expressed by a recombinant vaccinia virus.
Chakrabarti S; Mizukami T; Franchini G; Moss B
Virology; 1990 Sep; 178(1):134-42. PubMed ID: 2117828
[TBL] [Abstract][Full Text] [Related]
74. Design and synthesis of a highly immunogenic, discontinuous epitope of HIV-1 gp120 which binds to CD4+ve transfected cells.
Cotton GJ; Howie SE; Heslop I; Ross JA; Harrison DJ; Ramage R
Mol Immunol; 1996 Feb; 33(2):171-8. PubMed ID: 8649438
[TBL] [Abstract][Full Text] [Related]
75. Mutations in CD8 that affect interactions with HLA class I and monoclonal anti-CD8 antibodies.
Sanders SK; Fox RO; Kavathas P
J Exp Med; 1991 Aug; 174(2):371-9. PubMed ID: 1906921
[TBL] [Abstract][Full Text] [Related]
76. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding.
Celada F; Cambiaggi C; Maccari J; Burastero S; Gregory T; Patzer E; Porter J; McDanal C; Matthews T
J Exp Med; 1990 Oct; 172(4):1143-50. PubMed ID: 2212945
[TBL] [Abstract][Full Text] [Related]
77. An efficient phage plaque screen for the random mutational analysis of the interaction of HIV-1 gp120 with human CD4.
Tsui P; Sweet RW; Sathe G; Rosenberg M
J Biol Chem; 1992 May; 267(13):9361-7. PubMed ID: 1533631
[TBL] [Abstract][Full Text] [Related]
78. Antigen-independent adhesion of CD45RA (naive) and CD45RO (memory) CD4 T cells to B cells.
Lecomte O; Fischer A
Int Immunol; 1992 Feb; 4(2):191-6. PubMed ID: 1352461
[TBL] [Abstract][Full Text] [Related]
79. Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity.
Ashkenazi A; Smith DH; Marsters SA; Riddle L; Gregory TJ; Ho DD; Capon DJ
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7056-60. PubMed ID: 1871120
[TBL] [Abstract][Full Text] [Related]
80. A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus.
Berger EA; Fuerst TR; Moss B
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2357-61. PubMed ID: 2451247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
